Related Experiment Video
Updated: May 11, 2026

Expression and Purification of Virus-like Particles for Vaccination
Published on: June 2, 2016
Building better biotherapeutics and vaccines by design: EpiVax, Inc., an immunology company
Leonard Moise1, Annie De Groot, Anthony Marcello
1Senior director vaccine research at EpiVax.
Abstract:
EpiVax, Inc., is an early-stage informatics and immunology biotechnology company in Providence, Rhode Island. It applies computational tools to harness immunity in three major areas: immunomodulation, biotherapeutic immunogenicity risk assessment and de-risking, and vaccine development. Immunotherapy, bio-better and vaccine candidates under development at EpiVax promise to improve the health outcomes of millions of people affected by devastating immune-related diseases.
More Related Videos
Related Concept Videos
Microorganisms in Medicine and Therapeutics
Vaccine Production
Cancer Vaccines
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Vaccinations
Tumor Immunotherapy
Human Virome

